Active surveillance protocol in prostate cancer in Portugal

被引:1
|
作者
Gaspar, S. R. da Silva [1 ]
Fernandes, M. [1 ]
Castro, A. [1 ]
Oliveira, T. [1 ]
Dias, J. Santos [1 ]
dos Reis, J. Palma [1 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Urol, Lisbon, Portugal
来源
ACTAS UROLOGICAS ESPANOLAS | 2022年 / 46卷 / 06期
关键词
Active surveillance; Prostate cancer; Watchful waiting; Portugal; MRI; Biopsy; VERSION; 2; MEN; COMPLICATIONS; MANAGEMENT; BIOPSIES;
D O I
10.1016/j.acuro.2021.01.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine clinical practice patterns in locally managing patients under an active surveillance protocol among Portuguese urologists. Introduction: Prostate cancer (PCa) is a heterogeneous disease with many prostate adeno-carcinomas being indolent and a low probability of ever causing symptoms or death. Active surveillance (AS) is a form of conservative management aimed to reduce over-treatment for low-risk PCa patients. Over the years, experience with AS has grown considerably and is now standard in some countries, however a universal protocol still does not exist. Methods: Nationwide anonymous e-survey concerning habits and practices on AS among Portu-guese urologists, that consisted of 12 questions and was sent electronically to all 368 current members of the Portuguese Urological Association. Results: 56 urologists were surveyed (15.21% answer rate), evenly distributed geographically and allocated according to years of experience as well as number of PCa patients managed monthly. The vast majority of respondents recommends AS to their patients, particularly ISUP grade 1 patients, whose PSA serum level is bellow 20ng/mL. Observance of AS programs by patients was not in question but concerns exist over psychological morbidity while harboring disease. Majority believed that international guidelines surveillance protocols were adequate and sufficient, but there are some constraints concerning availability of periodic MRIs and re -biopsy needs. Conclusions: AS seems to be sustained in urologist clinical practice, although patients still lag to adhere and choose for active treatment. AS may not be an easy choice for patients and clinicians due to uncertainty of disease progression, risk of loss to follow-up and repeated biopsies but is also a cause for anxiety, depression, uncertainty and a perception of danger. (c) 2021 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:329 / 339
页数:11
相关论文
共 50 条
  • [41] Active surveillance for prostate cancer: How active is too active?
    Tosoian, Jeffrey J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [42] TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS)
    Macleod, Liam C.
    Ellis, William J.
    Newcomb, Lisa F.
    Zheng, Yingye
    Brooks, James D.
    Carroll, Peter R.
    Gleave, Martin E.
    Lance, Raymond S.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Wei, John T.
    Yang, Hui-Yu
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E755 - E755
  • [43] Obligatory Information that a Patient Diagnosed of Prostate Cancer and Candidate for an Active Surveillance Protocol must know
    Rubio-Briones, J.
    Iborra, I.
    Ramirez, M.
    Calatrava, A.
    Collado, A.
    Casanova, J.
    Dominguez-Escrig, J.
    Gomez-Ferrer, A.
    Ricos, J. V.
    Monros, J. L.
    Dumont, R.
    Lopez-Guerrero, J. A.
    Salas, D.
    Solsona, E.
    ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (09): : 559 - 565
  • [44] LONG TERM SURVIVAL OF PATIENTS WHO UNGERGO TREATMENT ON AN ACTIVE SURVEILLANCE PROTOCOL FOR PROSTATE CANCER
    Agarwal, Gautum
    Buethe, David
    Russell, Christopher
    Luchey, Adam
    Powsang, Julio
    JOURNAL OF UROLOGY, 2014, 191 (04): : E467 - E468
  • [45] Long term survival and predictors of disease reclassification in patients on an active surveillance protocol for prostate cancer
    Agarwal, Gautum
    Buethe, David
    Russell, Christopher
    Luchey, Adam
    Pow-Sang, Julio M.
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (02) : 8215 - 8219
  • [46] Active surveillance of prostate cancer: MRI and beyond
    Girometti, Rossano
    Giganti, Francesco
    EUROPEAN RADIOLOGY, 2024, 34 (10) : 6215 - 6216
  • [47] The Role of MRI in Active Surveillance for Prostate Cancer
    Fascelli, Michele
    George, Arvin K.
    Frye, Thomas
    Turkbey, Baris
    Choyke, Peter L.
    Pinto, Peter A.
    CURRENT UROLOGY REPORTS, 2015, 16 (06)
  • [48] Active surveillance in low risk prostate cancer
    Bozkurt, Ozan
    Demir, Omer
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 76 - 79
  • [49] Active surveillance for prostate cancer: a legal perspective
    Venderbos, Lionne D. F.
    Roobol, Monique J.
    de Hoogh, August N. L.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2014, 2 (04): : 323 - 331
  • [50] Active surveillance in prostate cancer: a concept analysis
    Horrill, Tara
    JOURNAL OF CLINICAL NURSING, 2016, 25 (7-8) : 1166 - 1172